BioAtla, Inc. (NASDAQ: BCAB) reported Q3 EPS of ($0.22), $0.19 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $11 million.

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.